Skip to main content

Table 1 Participant characteristics and vital signs of No AECOPD and AECOPD groups. Data are presented as mean [standard deviation] unless otherwise stated

From: A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study

 

No AECOPD

(n = 17)

AECOPD

(n = 14)

Male, n (%)

8 (52.9)

8 (57.1)

Age (years)

66.5 [8.5]

71.5 [8.1]

BMI (kg/m2)

25.9 [7.5]

24.6 [4.4]

FEV1 (% predicted)

38.5 [14.7]

48.9 [24.5]

FEV1/FVC ratioa

0.38 (0.35–0.41)

0.41 (0.31–0.56)

MRC: 2, n (%)

3 (17.6)

3 (21.4)

3, n (%)

3 (17.6)

2 (14.3)

4, n (%)

7 (41.2)

5 (35.7)

5A, n (%)

2 (11.8)

4 (28.6)

5B, n (%)

2 (11.8)

0

Smoking status: never, n (%)

0

0

Ex-smoker, n (%)

12 (70.6)

10 (71.4)

Current, n (%)

5 (29.4)

4 (28.6)

Pack years (years) a

50.0 (45.0–60.0)

42.5 (35.5–63.5)

Home O2 use, n (%)

2 (11.8)

2 (14.3)

Hospital admissions in last 12 monthsa

1.0 (0.0–3.0)

2.0 (1.0–2.0)

Exacerbations in last 12 monthsa

1.0 (1.0–1.0)

2.5 (2.0–38.)

Days worn (maximum of 42)a,*

28.0 (14.0–37.0)*

38.5 (33.3–41.0)

WT (hrs)

11.7 [1.6]

11.6 [2.3]

RR (breaths/min)

20.9 [3.9]

20.7 [3.5]

HR (bpm)

85.8 [9.3]

82.2 [9.9]

ST (°C)

34.1 [0.8]

34.5 [0.9]

Stationary (hrs/day)

10.2 [1.9]

10.4 [2.0]

PA (% of WT)a

10.4 (9.6–17.0)

8.9 (7.9–13.9)

PA (hrs/day)a,b

1.2 (0.9–2.1)

1.1 (0.7–1.5)

EXACT score

41.5 [11.9]

42.6 [12.9]

Comorbidities n (%)

Cardiac disease

7 (41.2)

4 (33.3)

Hypertension

8 (47.1)

4 (33.3)

Diabetes

4 (23.5)

0

Kidney disease

1 (5.9)

0

Musculoskeletal disorders

5 (29.4)

2 (29.4)

Mental health disorders

4 (23.5)

0

  1. BMI Body Mass Index, EXACT Exacerbations of Chronic Pulmonary Disease Tool, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, HR heart rate, MRC Medical Research Council, O2 Oxygen, PA physical activity, RR respiratory rate, ST skin temperature, WT wear time
  2. aData are presented as median (interquartile range). An unpaired T-test was used for parametric data and Mann–Whitney U test was used for non-parametric data. bCalculated using the Equivital LifeMonitor. *p < 0.05